165 related articles for article (PubMed ID: 34347919)
1. Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells.
Hu X; Liu Z; Duan X; Han X; Yuan M; Liu L; Xia X; Li N; Qin J; Wang Y
Mol Carcinog; 2021 Oct; 60(10):702-714. PubMed ID: 34347919
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis.
Yuan C; Zhang J; Lou J; Wang S; Jiang Y; Wu F; Wang S
Bioengineered; 2021 Dec; 12(1):3850-3863. PubMed ID: 34269158
[TBL] [Abstract][Full Text] [Related]
3. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231.
Gallagher SM; Castorino JJ; Wang D; Philp NJ
Cancer Res; 2007 May; 67(9):4182-9. PubMed ID: 17483329
[TBL] [Abstract][Full Text] [Related]
5. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract][Full Text] [Related]
6. MCT4 and CD147 colocalize with MMP14 in invadopodia and support matrix degradation and invasion by breast cancer cells.
Meng S; Sørensen EE; Ponniah M; Thorlacius-Ussing J; Crouigneau R; Larsen T; Borre MT; Willumsen N; Flinck M; Pedersen SF
J Cell Sci; 2024 Apr; 137(8):. PubMed ID: 38661040
[TBL] [Abstract][Full Text] [Related]
7. Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.
Li Z; Wu Q; Sun S; Wu J; Li J; Zhang Y; Wang C; Yuan J; Sun S
Biochem Biophys Res Commun; 2018 Jul; 501(4):962-967. PubMed ID: 29775610
[TBL] [Abstract][Full Text] [Related]
8. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.
Contreras-Baeza Y; Sandoval PY; Alarcón R; Galaz A; Cortés-Molina F; Alegría K; Baeza-Lehnert F; Arce-Molina R; Guequén A; Flores CA; San Martín A; Barros LF
J Biol Chem; 2019 Dec; 294(52):20135-20147. PubMed ID: 31719150
[TBL] [Abstract][Full Text] [Related]
9. SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma.
Zhao M; Huang C; Yang L; Pan B; Yang S; Chang J; Jin Y; Zhao G; Yue D; Qie S; Ren L
Cell Death Dis; 2023 Oct; 14(10):666. PubMed ID: 37816756
[TBL] [Abstract][Full Text] [Related]
10. Integration of a 'proton antenna' facilitates transport activity of the monocarboxylate transporter MCT4.
Noor SI; Pouyssegur J; Deitmer JW; Becker HM
FEBS J; 2017 Jan; 284(1):149-162. PubMed ID: 27860283
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).
Narumi K; Kobayashi M; Otake S; Furugen A; Takahashi N; Ogura J; Itagaki S; Hirano T; Yamaguchi H; Iseki K
Int J Pharm; 2012 May; 428(1-2):25-32. PubMed ID: 22426323
[TBL] [Abstract][Full Text] [Related]
12. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
[TBL] [Abstract][Full Text] [Related]
13. MCT4 knockdown by tumor microenvironment-responsive nanoparticles remodels the cytokine profile and eradicates aggressive breast cancer cells.
Abdellatif AAH; Bouazzaoui A; Tawfeek HM; Younis MA
Colloids Surf B Biointerfaces; 2024 Jun; 238():113930. PubMed ID: 38692174
[TBL] [Abstract][Full Text] [Related]
14. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
[TBL] [Abstract][Full Text] [Related]
15. Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
Todenhöfer T; Seiler R; Stewart C; Moskalev I; Gao J; Ladhar S; Kamjabi A; Al Nakouzi N; Hayashi T; Choi S; Wang Y; Frees S; Daugaard M; Oo HZ; Fisel P; Schwab M; Schaeffeler E; Douglas J; Hennenlotter J; Bedke J; Gibb EA; Fazli L; Stenzl A; Black PC
Mol Cancer Ther; 2018 Dec; 17(12):2746-2755. PubMed ID: 30262589
[TBL] [Abstract][Full Text] [Related]
16. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
17. Exercise rapidly increases expression of the monocarboxylate transporters MCT1 and MCT4 in rat muscle.
Coles L; Litt J; Hatta H; Bonen A
J Physiol; 2004 Nov; 561(Pt 1):253-61. PubMed ID: 15388779
[TBL] [Abstract][Full Text] [Related]
18. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
[TBL] [Abstract][Full Text] [Related]
19. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
